Astrana Health, Inc.

ASTH

US03763A2078

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
36.72 ^USD	+0.44%		-1.34%	-4.13%

Apr. 24	Astrana Health, Inc. Announces Redesignation of Albert Young from Chief Administrative Officer to A New Role as Senior Vice President of Health Affairs	CI
Apr. 02	Astrana Health Completes Acquisition of Community Family Care Medical Group	MT

Apollo Medical Holdings, Inc. will Change its Ticker to ASTH from AMEH

February 26, 2024 at 12:00 am EST

Effective February 26, 2024, Apollo Medical Holdings, Inc. will change its Nasdaq Capital Market stock ticker symbol to ASTH from AMEH.

Latest news about Astrana Health, Inc.

Astrana Health, Inc. Announces Redesignation of Albert Young from Chief Administrative Officer to A New Role as Senior Vice President of Health Affairs	Apr. 24	CI
Astrana Health Completes Acquisition of Community Family Care Medical Group	Apr. 02	MT
Astrana Health Management, Inc. completed the acquisition of All Assets of Community Family Care Medical Group IPA.	Mar. 30	CI
Truist Securities Adjusts Price Target on Astrana Health to $44 From $41, Maintains Hold Rating	Mar. 01	MT
Transcript : Apollo Medical Holdings, Inc., Q4 2023 Earnings Call, Feb 27, 2024	Feb. 27
Astrana Health, Inc. Provides Earnings Guidance for the Year Ending December 31, 2024	Feb. 27	CI
Astrana Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 27	CI
Jefferies Starts Coverage on Apollo Medical With Buy Rating	Feb. 26	MT
Apollo Medical Holdings, Inc. will Change its Ticker to ASTH from AMEH	Feb. 26	CI
Apollo Medical Holdings, Inc. will Change its Name to Astrana Health	Feb. 26	CI
Astrana Health, Inc.(NasdaqCM:ASTH) added to NASDAQ Composite Index	Feb. 25	CI
North American Morning Briefing : S&P 500 Futures -2-	Feb. 23	DJ
Astrana Health, Inc.(NasdaqCM:ASTH) dropped from NASDAQ Composite Index	Feb. 22	CI
Apollo Medical to Change Name to Astrana Health, Effective Monday	Feb. 22	MT
Apollo Medical to Rebrand as Astrana Health, Appoints Co-Chief Executive as CEO	Jan. 24	MT
Stifel Starts Coverage on Apollo Medical with Buy Rating, $45 Price Target	Jan. 24	MT
Apollo Medical Holdings, Inc. Announces Executive Changes	Jan. 24	CI
Apollo Medical Holdings, Inc. Announces Management Changes	Jan. 24	CI
Transcript : Apollo Medical Holdings, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 01:30 PM	Jan. 10
Truist Initiates Apollo Medical With Hold Rating, Price Target is $41	Dec. 22	MT
Tranche Update on Apollo Medical Holdings, Inc.'s Equity Buyback Plan announced on December 15, 2022.	Nov. 09	CI
Apollo Medical Holdings to Seek M&A	Nov. 07	CI
Transcript : Apollo Medical Holdings, Inc., Q3 2023 Earnings Call, Nov 07, 2023	Nov. 07
Apollo Medical Holdings, Inc. announces an Equity Buyback for $100 million worth of its shares.	Nov. 07	CI
Apollo Medical Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI

Astrana Health, Inc. is a healthcare company. The Company provides care coordination services to each constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company's Care Enablement segment is an integrated, end-to-end clinical and administrative platform, powered by its technology suite, which provides operational, clinical, financial, technology, management, and strategic services. Its Care Partners segment is focused on building and managing provider networks by partnering with provider partners for coordinated care delivery. Its Care Delivery segment is a data-driven care delivery organization focused on delivering accessible care to all patients. Its care delivery organization includes primary care, multi-specialty care, and ancillary care services.

Sector

Healthcare Facilities & Services

Calendar

2024-05-01 - Q1 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Astrana Health, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

36.72 USD

Average target price

54 USD

Spread / Average Target

+47.06%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
ASTRANA HEALTH, INC.	-4.13%	1.77B
CVS HEALTH CORPORATION	-14.92%	84.68B
HCA HEALTHCARE, INC.	+13.30%	81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+10.92%	29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-12.71%	16.73B
FRESENIUS SE & CO. KGAA	-3.06%	16.36B
QUEST DIAGNOSTICS INCORPORATED	-2.63%	14.92B
PURE HEALTH HOLDING	-31.75%	11.77B
FRESENIUS MEDICAL CARE AG	-1.42%	11.72B
DAVITA INC.	+27.44%	11.71B

Other Healthcare Facilities & Services

Astrana Health, Inc.

Equities

ASTH

US03763A2078

Healthcare Facilities & Services

Apollo Medical Holdings, Inc. will Change its Ticker to ASTH from AMEH

Latest news about Astrana Health, Inc.

Chart Astrana Health, Inc.

Company Profile

Income Statement Evolution

Ratings for Astrana Health, Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Healthcare Facilities & Services